Hakan KESKİN, Hülya DİROL, Makbule ERGİN

Surgical management outcomes of tuberculosis with hemoptysis and without hemoptysis

Purpose: Increased complication risk of surgical interventions performed in patients with hemoptysis is a common concern among surgeons. Therefore, here, we investigated the surgical outcomes of tuberculosis patients with hemoptysis. Materials and methods: Patients, between 1985 and 2018, diagnosed with tuberculosis surgically, were analyzed retrospectively. The patients were divided into two groups; those without hemoptysis (Group 1) and those with hemoptysis (Group 2). The analysis included age, gender, symptoms, comorbidities, Positron Emission Tomography-Computed Tomography (PET-CT) findings, surgical interventions, perioperative complications, lengths of hospital stay, recurrence of hemoptysis, and comparison of Group 1 and 2. Results: 541 patients with pulmonary tuberculosis diagnosed surgically were analyzed. 448 patients were in Group 1 and 93 patients were in Group 2. The patients in Group 2 were significantly younger than the patients in Group 1 (Group 1 mean age 57.8±6.2, Group 2 mean age 31.2±5.3, p

Hemoptizi olan ve olmayan tüberkülozlu hastaların cerrahi tedavi sonuçları

Amaç: Hemoptizi hastalarında uygulanan cerrahi girişimlerin artmış komplikasyon riski cerrahlar arasında yaygın bir endişedir. Bu nedenle burada hemoptizi olan tüberküloz hastalarının cerrahi sonuçlarını araştırdık. Gereç ve yöntem: 1985-2018 yılları arasında cerrahi olarak tüberküloz tanısı alan hastalar retrospektif olarak incelendi. Hastalar iki gruba ayrıldı; hemoptizi olmayanlar (Grup 1) ve hemoptizi olanlar (Grup 2). Analiz yaş, cinsiyet, semptomlar, komorbiditeler, Pozitron Emisyon Tomografisi-Bilgisayarlı Tomografi (PET-CT) bulguları, cerrahi müdahaleler, perioperatif komplikasyonlar, hastanede kalış süreleri, hemoptizi nüksü ve Grup 1 ve 2'nin karşılaştırmasını içeriyordu. Bulgular: Cerrahi olarak teşhis edilen akciğer tüberkülozu olan 541 hasta incelendi. Grup 1'de 448 hasta, Grup 2'de 93 hasta vardı. Grup 2'deki hastalar Grup 1'deki hastalara göre anlamlı olarak daha gençti (Grup 1 ortalama yaş 57,8±6,2, Grup 2 ortalama yaş 31,2±5,3, p

PDF

___

1. Albay A, Güney M, Tekin K, Kısa Ö, Sığ AK. Pulmoner ve ekstrapulmoner örneklerde tüberkülozun erken tanısı ve rifampisin direncinin tespiti için geneXpert MTB/RIF testinin değerlendirilmesi. Cukurova Med J 2016;41:548-553. https://doi.org/10.17826/ cukmedj.237514

2. Furin J, Cox H, Pai M. Tuberculosis. Lancet 2019;393:1642-1656. https://doi.org/10.1016/S0140- 6736(19)30308-3

3. Zhang Y, Chen C, Jiang GN. Surgery of massive hemoptysis in pulmonary tuberculosis: immediate and long-term outcomes. J Thorac Cardiovasc Surg 2014;148:651-656. https://doi.org/10.1016/j. jtcvs.2014.01.008

4. Erdogan A, Yegin A, Gürses G, Demircan A. Surgical management of tuberculosis-related hemoptysis. Ann Thorac Surg 2005;79:299-302. https://doi. org/10.1016/j.athoracsur.2004.05.016

5. Cortés Julián G, Valencia LC, Ríos Pascual S, de la Rosa Abarroa MA, Guzmánde Alba E. Complications of surgery for infectious lung cavities. Asian Cardiovasc Thorac Ann 2018;26:120-126. https://doi. org/10.1177/0218492318754740

6. Halezeroğlu S, Okur E. Thoracic surgery for haemoptysis in the context of tuberculosis: what is the best management approach? J Thorac Dis 2014;6:182-185. https://doi.org/10.3978/j.issn.2072- 1439.2013.12.25

7. Evman S, Baysungur V, Alpay L, et al. Management and surgical outcomes of concurrent tuberculosis and lung cancer. Thorac Cardiovasc Surg 2017;65:542- 545. https://doi.org/10.1055/s-0036-1583167

8. Reid MJA, Arinaminpathy N, Bloom A, et al. Building a tuberculosis-free world: the lancet commission on tuberculosis. Lancet 2019;393:1331-1384. https://doi. org/10.1016/S0140-6736(19)30024-8

9. Echazarreta A, Zerbini E, De Sandro J, et al. Tuberculosis and comorbidities in urban areas in Argentina. A gender and age perspective. Biomedica 2018;15;38:180-188. http://dx.doi.org/10.7705/ biomedica.v38i0.3904

10. Gandhi S, Jaiswal A, Joshi S, Shetty N, Shah I. Rasmussen’s aneurysm in a child with multidrug resistant pulmonary tuberculosis. Indian J Pediatr 2020;87:1-3. https://doi.org/10.1007/s12098-020- 03211-4

11. Garay Stuart M. Pulmonary tuberculosis. In: N Rom William, Garay Stuart M. editors. Tuberculosis. 2nd ed. Lippincott Williams & Wilkins; Philadelphia 2004:367- 368.

12. Dewan RK, Pezzella AT. Surgical aspects of pulmonary tuberculosis: an update. Asian Cardiovasc Thor Ann 2016;24:835-846. http://dx.doi. org/10.1177/0218492316661958

13. Subotic D, Yablonskiy P, Sulis G, et al. Surgery and pleuro-pulmonary tuberculosis: a scientific literature review. J Thorac Dis 2016;8:474-485. http://dx.doi. org/10.21037/jtd.2016.05.59

14. Lowe VJ, Fletcher JW, Gobar L, et al. Prospective investigation of positron emission tomography in lung nodules. J Clin Oncol 1998;16:1075-1084. http:// dx.doi.org/10.1200/JCO.1998.16.3.1075

15. Hashimoto Y, Tsujikawa T, Kondo C, et al. Accuracy of PET for diagnosis of solid pulmonary lesions with 18F-FDG uptake below the standardized uptake value of 2.5. J Nucl Med 2006;47:426-431. Available at: https://jnm.snmjournals.org/content/47/3/426.long. Accessed December 17, 2020

16. Du Toit R, Shaw JA, Irusen EM, Von Groote Bidlingmaier F, Warwick JM, Koegelenberg CFN. The diagnostic accuracy of integrated positron emission tomography/ computed tomography in the evaluation of pulmonary mass lesions in a tuberculosis-endemicarea. S Afr Med J 2015;105:1049-1052. http://dx.doi.org/10.7196/ SAMJ.2015.v105i12.10300

17. Marfina GY, Vladimirov KB, Avetisian AO, et al. Bilateral cavitary multidrug- or extensively drug-resistant tuberculosis: role of surgery. Eur J Cardiothorac Surg 2018;4:618-624. http://dx.doi.org/10.1093/ejcts/ ezx350

18. Sathekge MM, Maes A, Pottel H, Stoltz A, Van de Wiele C. Dual time-point FDG PET/CT for differentiating benign from malignant solitary pulmonary nodules in a TB endemic area. S Afr Med J 2010;100:598-601. https://doi.org/10.7196/samj.4082

19. Yun JS, Song SY, Na KJ, et al. Surgery for hemoptysis in patients with benign lung disease. J Thorac Dis 2018;10:3532-3538. https://doi.org/10.21037/ jtd.2018.05.122